Gertrude Biomedical

Gertrude Biomedical is a biotechnology company dedicated to developing small molecule inhibitors of the SOX18 transcription factor. Its strategy focuses on the control of abnormal vascular growth by targeting key gene transcription factors. The company centers on the treatment of serious human diseases, which depend on aberrant vasculature for their growth and spread.